ReachMD

Be part of the knowledge.™

Neurology and Neurosurgery

148

LikeLikedUnlike

Episodes 16-30 of 97

Case Study: Adjusting STOP-BANG Screening Criteria for Minority Ethnic Groups
MinuteCE®
Case Study: Adjusting STOP-BANG Screening Criteria for Minority Ethnic Groups
- Christina Finch, MD
  Peer
1.00 program credits
Roundtable: Safety and Efficacy Data on New Therapies for Excessive Daytime Sleepiness in Obstructive Sleep Apnea
MinuteCE®
Roundtable: Safety and Efficacy Data on New Therapies for Excessive Daytime Sleepiness in Obstructive Sleep Apnea
- Atul Malhotra, MD
  Peer
- Neomi Shah, MD, MPH, MSc
  Peer
1.00 program credits
Algorithm for Assessing Excessive Daytime Sleepiness in Obstructive Sleep Apnea
MinuteCE®
Algorithm for Assessing Excessive Daytime Sleepiness in Obstructive Sleep Apnea
- Neomi Shah, MD, MPH, MSc
  Peer
1.00 program credits
MinuteCE®
Obstructive Sleep Apnea: Emerging Therapies for Excessive Daytime Sleepiness
- Atul Malhotra, MD
  Peer
- Christina Finch, MD
  Peer
- Neomi Shah, MD, MPH, MSc
  Peer
1.00 credits 9 episodes
MinuteCE®
Sodium Oxybate: A Standard of Care for the Management of Narcolepsy for 20 Years
- Michael J. Thorpy, MD
  Peer
- Clete A. Kushida, MD, PhD
  Peer
- Anne Marie Morse, DO
  Peer
- Franz H. Messerli, MD
  Peer
1.00 credits 10 episodes
MinuteCE®
Keeping It Real: Reversing Effects of Anticoagulation in the Modern Era with Real World Data
- Jan Beyer-Westendorf, MD, PhD
  Peer
- Craig I. Coleman, PharmD, FASHP
  Peer
- Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
  Peer
- Deborah Siegal, MD, MSc, FRCPC
  Peer
1.50 credits 8 episodes
Newest Emerging Data from ISTH: Andexanet Alfa vs. 4F-PCC?
MinuteCE®
Newest Emerging Data from ISTH: Andexanet Alfa vs. 4F-PCC?
- Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
  Peer
1.50 program credits
Meaningfulness of ISTH Chart Audit of In-hospital Mortality for GI Bleeds?
MinuteCE®
Meaningfulness of ISTH Chart Audit of In-hospital Mortality for GI Bleeds?
- Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
  Peer
1.50 program credits
What Future Studies Are Out There on the Meaningfulness of Reversal in ICH?
MinuteCE®
What Future Studies Are Out There on the Meaningfulness of Reversal in ICH?
- Craig I. Coleman, PharmD, FASHP
  Peer
1.50 program credits
What’s the Best Available Evidence for Reversal of Life-Threatening Bleeds?
MinuteCE®
What’s the Best Available Evidence for Reversal of Life-Threatening Bleeds?
- Craig I. Coleman, PharmD, FASHP
  Peer
1.50 program credits
Clinical and Practical Viability of RWE – What Now?
MinuteCE®
Clinical and Practical Viability of RWE – What Now?
- Craig I. Coleman, PharmD, FASHP
  Peer
- Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
  Peer
1.50 program credits
Setting the Stage: Case Considerations for Bleeding Management in Anticoagulated Patients
MinuteCE®
Setting the Stage: Case Considerations for Bleeding Management in Anticoagulated Patients
- Jan Beyer-Westendorf, MD, PhD
  Peer
1.50 program credits
Meaningfulness of ISTH Chart Audit of In-hospital Mortality for ICH?
MinuteCE®
Meaningfulness of ISTH Chart Audit of In-hospital Mortality for ICH?
- Paul P. Dobesh, PharmD, FACC, FAHA, FCCP, BCPS, BCCP
  Peer
1.50 program credits
Anticoagulant-Associated Major Bleeding Is a Significant Problem: How Do I Address?
MinuteCE®
Anticoagulant-Associated Major Bleeding Is a Significant Problem: How Do I Address?
- Deborah Siegal, MD, MSc, FRCPC
  Peer
1.50 program credits
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease – Primary Care Module
CME/CE
Understanding the Fine Print: The Who, When, And What To Do About ARIA in Patients with Alzheimer’s Disease – Primary Care Module
- James Galvin, MD, MPH, FANA
  Peer
- Jon Toledo, MD, PhD
  Peer
- Charles P. Vega, MD
  Peer
0.50 credits

Program Chapters

Segment Chapters

Playlist:

Recommended